After adjusting for other prognostic factors (age, stage, grade, and tumor residual size), low ZNF76 expression was also significantly associated with shorter PFS and OS (P=0.027, P=0.038; Table 4), demonstrating that ZNF76 expression is an independent predictor of poorer clinical outcome in patients with OV. This evidence concerns the gene ZNF76 and neoplasm.